Department of Physical Therapy, Wentworth Douglass Hospital, Dover, NH 03820, USA.
Center for Neuroplasticity and Pain, SMI, School of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.
Medicina (Kaunas). 2023 Jul 28;59(8):1380. doi: 10.3390/medicina59081380.
Trigger points (TrPs) are prevalent in patients with migraine headaches. Needling interventions targeting TrPs in migraine patients may reduce the intensity and frequency of headaches, yet systematic reviews reveal a lack of robust evidence. Intramuscular electrical stimulation (IMES) is a modality that delivers electrical current into muscles and TrPs, with recent studies suggesting it may amplify the therapeutic effects of dry needling peripherally and centrally. This could be advantageous for patients with migraine and symptomatic TrPs. This study will implement a multiple baseline single-case experimental design (SCED). In a clinical setting, a SCED study lends itself to conducting research with only a few patients that each serve as their own controls. In this SCED study, four participants with chronic migraine will be enrolled in a non-concurrent manner and randomized to one of four baseline measurement periods (4, 5, 6 or 7 weeks), leading to four potentially different start dates for each participant in the intervention phase. During the intervention phase, patients will receive five sessions of dry needling with IMES, one session per week for five weeks. The primary outcome measure will be headache frequency, i.e., the reduction in the number of headache days over a one-month period using electronic headache diary data from the Migraine Buddy smartphone application. Secondary outcome measures will be changes in mean migraine pain intensity using a numeric pain rating scale (NPRS), migraine disability using the Migraine Disability Assessment Test (MIDAS), the Headache Impact Test (HIT-6), and changes in selected cervical musculoskeletal impairments including pressure pain thresholds (PPTs) over TrPs, the craniocervical flexion test (CCFT), and cervical active range of motion (AROM). Primary and secondary outcome measures will be analyzed separately using both visual and statistical analyses. : Actively recruiting participants. This project was approved by the Mass General Brigham Institutional Review Board (protocol #2023P000931) and is registered with ClinicalTrials.gov (NCT05893914). : This study will seek to determine the effects of a five-week intervention period of IMES to TrPs in the posterior cervical muscles of subjects with chronic migraine.
触发点(TrPs)在偏头痛患者中很常见。针对偏头痛患者 TrPs 的针刺干预措施可能会降低头痛的强度和频率,但系统评价显示缺乏强有力的证据。肌肉内电刺激(IMES)是一种将电流输送到肌肉和 TrPs 的方法,最近的研究表明,它可能会在周围和中枢放大干针的治疗效果。对于患有偏头痛和症状性 TrPs 的患者来说,这可能是有利的。本研究将采用多基线单病例实验设计(SCED)。在临床环境中,SCED 研究适合对只有少数患者进行研究,每个患者都作为自己的对照。在这项 SCED 研究中,将以非连续的方式招募四名患有慢性偏头痛的参与者,并随机分配到四个基线测量期之一(4、5、6 或 7 周),这将导致每个参与者在干预阶段有四个潜在的不同开始日期。在干预阶段,患者将每周接受一次为期五周的干针加 IMES 治疗,共五次。主要结局指标是头痛频率,即使用 Migraine Buddy 智能手机应用程序的电子头痛日记数据,在一个月内头痛天数的减少。次要结局指标是使用数字疼痛评分量表(NPRS)测量的平均偏头痛疼痛强度的变化、偏头痛残疾程度使用偏头痛残疾评估测试(MIDAS)、头痛影响测试(HIT-6)以及包括 TrPs 处的压力疼痛阈值(PPT)、颅颈屈曲试验(CCFT)和颈椎主动活动范围(AROM)在内的选定颈椎肌肉骨骼损伤的变化。主要和次要结局指标将分别使用视觉和统计分析进行分析。:正在积极招募参与者。该项目已获得马萨诸塞州综合医院布赖根妇女医院机构审查委员会的批准(协议号 2023P000931),并在 ClinicalTrials.gov 注册(NCT05893914)。:本研究旨在确定在后颈部肌肉的 TrPs 进行为期五周的 IMES 干预对慢性偏头痛患者的影响。